BE848545A - Derives n-methylene substitues de thienamycine, - Google Patents

Derives n-methylene substitues de thienamycine,

Info

Publication number
BE848545A
BE848545A BE172525A BE172525A BE848545A BE 848545 A BE848545 A BE 848545A BE 172525 A BE172525 A BE 172525A BE 172525 A BE172525 A BE 172525A BE 848545 A BE848545 A BE 848545A
Authority
BE
Belgium
Prior art keywords
emi
carbon atoms
alkyl
compound according
hydrogen
Prior art date
Application number
BE172525A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE848545A publication Critical patent/BE848545A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BE172525A 1975-11-21 1976-11-19 Derives n-methylene substitues de thienamycine, BE848545A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63429675A 1975-11-21 1975-11-21

Publications (1)

Publication Number Publication Date
BE848545A true BE848545A (fr) 1977-05-20

Family

ID=24543219

Family Applications (1)

Application Number Title Priority Date Filing Date
BE172525A BE848545A (fr) 1975-11-21 1976-11-19 Derives n-methylene substitues de thienamycine,

Country Status (4)

Country Link
JP (1) JPS5285188A (cs)
BE (1) BE848545A (cs)
CS (1) CS226166B2 (cs)
ZA (1) ZA766973B (cs)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0006639A1 (en) * 1978-07-03 1980-01-09 Merck & Co. Inc. Crystalline N-formimidoyl thienamycin
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
EP0010573A1 (en) 1978-07-24 1980-05-14 Merck & Co. Inc. Novel Z-2-acylamino-3-monosubstituted propenic acids and their esters and salts, and processes for preparing them
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
US4260543A (en) * 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
US4262010A (en) * 1979-12-03 1981-04-14 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids
US4335043A (en) 1977-11-17 1982-06-15 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4376774A (en) 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0017992A1 (en) * 1979-04-19 1980-10-29 Merck & Co. Inc. 2-Substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids, processes for preparing them, antibiotic pharmaceutical compositions containing same and process for preparing intermediates

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4194047A (en) * 1975-11-21 1980-03-18 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
US4232030A (en) * 1977-09-15 1980-11-04 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin sulfoxide and sulfone
US4335043A (en) 1977-11-17 1982-06-15 Merck & Co., Inc. Substituted N-methylene derivatives of thienamycin
EP0006639A1 (en) * 1978-07-03 1980-01-09 Merck & Co. Inc. Crystalline N-formimidoyl thienamycin
US4260543A (en) * 1978-07-03 1981-04-07 Merck & Co., Inc. Crystalline N-formimidoyl thienamycin
EP0010573A1 (en) 1978-07-24 1980-05-14 Merck & Co. Inc. Novel Z-2-acylamino-3-monosubstituted propenic acids and their esters and salts, and processes for preparing them
US4376774A (en) 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
US4262010A (en) * 1979-12-03 1981-04-14 Merck & Co., Inc. 6-(1-Hydroxyethyl)-2-(2-aminoethylthio)-1,1-disubstituted-1-carbadethiapen-2-em-3-carboxylic acids

Also Published As

Publication number Publication date
ZA766973B (en) 1978-06-28
JPS5285188A (en) 1977-07-15
JPS61347B2 (cs) 1986-01-08
CS226166B2 (cs) 1984-03-19

Similar Documents

Publication Publication Date Title
FI84826B (fi) Foerfarande foer framstaellning av 6 -(1-hydroxietyl-2-substituerad-2-karbapenem-3-karboxylsyror anvaendbara som laekemedel.
FR2471382A1 (fr) Nouveaux derives antibacteriens de 7-oxo-4-thia-1-azabicyclo (3.2.0) hept-2-ene, leur procede de production et composition les contenant
US4217453A (en) 6-Amido-3-substituted-amino-1-azabicyclo[3.2.0]hept-2-en-7-one-2-carboxylic acid
FR2528847A1 (fr) Produits nouveaux de la classe des carbapenems et leur application en tant qu'antibiotiques
BE848545A (fr) Derives n-methylene substitues de thienamycine,
EP0045198A2 (en) 1,1-Disubstituted carba-2-penems and their production
FR2524890A1 (fr) Nouveaux derives de carbapenem, compositions pharmaceutiques les contenant, composes intermediaires pour leur preparation, et leurs procedes de production
HU194889B (en) Process for producing peneme derivatives and pharmaceutical compositions containing them
CH628051A5 (en) Process for the preparation of N-alkylated derivatives of thienamycin
FR2533568A1 (fr) Nouveaux antibiotiques de la classe des carbapenems, et leur application pharmaceutique
DE3725375A1 (de) Stabile oxapenem-3-carbonsaeuren
US4298741A (en) 6-Amido-3-substituted-1-azabicyclo[3.2.0]-hept-2-en-7-one-2-carboxylic acid
US4613595A (en) Penem derivatives, and composition containing them
JPS6259107B2 (cs)
FR2499081A1 (fr) Derives de 7-oxo-1-azabicyclo (3-2-0) hept-2-ene, leur preparation et leur application en tant que medicaments
EP0362622B1 (de) Verwendung stabiler Oxapenem-3-carbonsäuren zur Herstellung Beta-Lactamase hemmender Arzneimittel
HU198943B (en) Process for producing 2-/methoxymethyl/-penem derivatives and pharmaceutical compositions comprising same
US4374849A (en) 6-Amidocyclonocardicins
JPS63162694A (ja) ペネム誘導体、その製造法およびその用途
BE897854A (fr) Derives de carbapeneme antibiotiques
JPS63310888A (ja) 新規化合物、その製法及びそれを含む医薬組成物
US4423055A (en) 6-Substituted-hydrocarbon-2-(substituted-thio)penem-3-carboxylic acids
EP1100800B1 (en) Novel c-2 s/o- and s/n formaldehyde acetal derivatives of carbapenem-3-carboxylic acids and their use as antibiotics and beta-lactamase inhibitors
GB1570987A (en) Thienamycin derivatives
CH633800A5 (en) Process for the preparation of guanidines

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: MERCK & CO. INC.

Effective date: 19961119